Exelixis (EXEL) Reiterated at Market Outperform by Citizens on Positive Q2 Script Growth

July 22, 2026 4:15 AM

Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $55.00 price target on Exelixis (NASDAQ: EXEL).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found